Legal Representation
Attorney
Susan O. Goldsmith
USPTO Deadlines
Next Deadline
1543 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-10-24)
Due Date
October 24, 2029
Grace Period Ends
April 24, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Oct 24, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Oct 24, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Aug 8, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Aug 8, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jul 19, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jul 3, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jun 26, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jun 26, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jun 26, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jun 26, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jun 12, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jun 12, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jun 12, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jun 8, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 8, 2023 | ATRV | O | ATTORNEY REVIEW COMPLETED | Loading... |
Dec 9, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
Dec 9, 2022 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
Oct 19, 2022 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
Aug 25, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Aug 25, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 010
Implantable and rechargeable medical device in the nature of an implantable heart stimulator made of artificial materials, for the treatment of chronic heart failure disease and a transcutaneous charger sold therewith; Implantable and rechargeable medical device in the nature of an implantable heart stimulator, which includes rescue cardiac defibrillation capabilities, made of artificial materials, for the treatment of chronic heart failure disease and a transcutaneous charger sold therewith
First Use Anywhere:
Nov 29, 2007
First Use in Commerce:
May 6, 2019
Classification
International Classes
010
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"IMPULSE"